TY - JOUR
T1 - Genetically Encoding Ultrastable Virus-like Particles Encapsulating Functional DNA Nanostructures in Living Bacteria
AU - Zilberzwige-Tal, Shai
AU - Alon, Dan Mark
AU - Gazit, Danielle
AU - Zachariah, Shahar
AU - Hollander, Amit
AU - Gazit, Ehud
AU - Elbaz, Johann
N1 - Publisher Copyright:
© 2021 American Chemical Society.
PY - 2021/8/20
Y1 - 2021/8/20
N2 - DNA nanotechnology is leading the field of in vitro molecular-scale device engineering, accumulating to a dazzling array of applications. However, while DNA nanostructures' function is robust under in vitro settings, their implementation in real-world conditions requires overcoming their rapid degradation and subsequent loss of function. Viruses are sophisticated supramolecular assemblies, able to protect their nucleic acid content in inhospitable biological environments. Inspired by this natural ability, we engineered in vitro and in vivo technologies, enabling the encapsulation and protection of functional DNA nanostructures inside MS2 bacteriophage virus-like particles (VLPs). We demonstrate the ssDNA-VLPs nanocomposites' (NCs) abilities to encapsulate single-stranded-DNA (ssDNA) in a variety of sizes (200-1500 nucleotides (nt)), sequences, and structures while retaining their functionality. Moreover, by exposing these NCs to hostile biological conditions, such as human blood serum, we exhibit that the VLPs serve as an excellent protective shell. These engineered NCs pose critical properties that are yet unattainable by current fabrication methods.
AB - DNA nanotechnology is leading the field of in vitro molecular-scale device engineering, accumulating to a dazzling array of applications. However, while DNA nanostructures' function is robust under in vitro settings, their implementation in real-world conditions requires overcoming their rapid degradation and subsequent loss of function. Viruses are sophisticated supramolecular assemblies, able to protect their nucleic acid content in inhospitable biological environments. Inspired by this natural ability, we engineered in vitro and in vivo technologies, enabling the encapsulation and protection of functional DNA nanostructures inside MS2 bacteriophage virus-like particles (VLPs). We demonstrate the ssDNA-VLPs nanocomposites' (NCs) abilities to encapsulate single-stranded-DNA (ssDNA) in a variety of sizes (200-1500 nucleotides (nt)), sequences, and structures while retaining their functionality. Moreover, by exposing these NCs to hostile biological conditions, such as human blood serum, we exhibit that the VLPs serve as an excellent protective shell. These engineered NCs pose critical properties that are yet unattainable by current fabrication methods.
KW - DNA nanostructures
KW - MS2 VLPs
KW - aptamers
KW - nanocomposites
KW - ssDNA encapsulation
UR - http://www.scopus.com/inward/record.url?scp=85108512667&partnerID=8YFLogxK
U2 - 10.1021/acssynbio.0c00586
DO - 10.1021/acssynbio.0c00586
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34077194
AN - SCOPUS:85108512667
SN - 2161-5063
VL - 10
SP - 1798
EP - 1807
JO - ACS Synthetic Biology
JF - ACS Synthetic Biology
IS - 8
ER -